ArticleFrontiers in cardiovascular medicine2026

Shexiang Tongxin dropping pill for coronary microvascular disease: rationale and design of a multicenter randomized trial with a cardiopulmonary exercise testing primary endpoint and AI-enhanced myocardial contrast echocardiograph.

Meiyi Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.